Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 1,198,500 | N/A |
| Marketable Securities | N/A | N/A | N/A | 2,877,000 | N/A |
| Receivables | N/A | N/A | N/A | 8,557,500 | N/A |
| Inventories | N/A | N/A | N/A | 6,963,000 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $19,596,000 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 315,000 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 355,500 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $670,500 | $N/A |
| Total Assets | $N/A | $N/A | $N/A | $41,013,000 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,152,000 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 1,242,000 | N/A |
| Other current liabilities | N/A | N/A | N/A | 4,120,500 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $8,229,000 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,752,500 | N/A |
| aiOther Non-Current Liabilities | 0 | 0 | 0 | 3,073,500 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $5,826,000 | $N/A |
| Total Liabilities | $N/A | $N/A | $N/A | $14,055,000 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 1,131,000 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 21,979,500 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $26,958,000 | $N/A |
| Total Liabilities And Equity | $0 | $0 | $0 | $41,013,000 | $0 |